Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

May 14, 2021

Study Completion Date

November 30, 2021

Conditions
Neovascular (Wet) Age-Related Macular Degeneration
Interventions
DRUG

aflibercept

Intravitreally (IVT) administered as a liquid formulation in a vial

DRUG

High-dose aflibercept

Intravitreally (IVT) administered as a liquid formulation in a vial

Trial Locations (46)

11021

Regeneron Study Site, Great Neck

18704

Regeneron Study Site, Kingston

21740

Regeneron Study Site, Hagerstown

22031

Regeneron Study Site, Fairfax

26506

Regeneron Study Site, Morgantown

28210

Regeneron Study Site, Charlotte

28803

Regeneron Study Site, Asheville

29169

Regeneron Study Site, West Columbia

29456

Regeneron Study Site, Ladson

30060

Regeneron Study Site, Marietta

30909

Regeneron Study Site, Augusta

32308

Regeneron Study Site, Tallahassee

32901

Regeneron Study Site, Melbourne

33309

Regeneron Study Site, Fort Lauderdale

33770

Regeneron Study Site, Largo

33805

Regeneron Study Site, Lakeland

33880

Regeneron Study Site, Winter Haven

33912

Regeneron Study Site, Fort Myers

43212

Regeneron Study Site, Columbus

48073

Regeneron Study Site, Royal Oak

57701

Regeneron Study Site, Rapid City

60452

Regeneron Study Site, Oak Forest

73013

Regeneron Study Site, Edmond

76012

Regeneron Study Site, Arlington

77030

Regeneron Study Site, Houston

77384

Regeneron Study Site, The Woodlands

78705

Regeneron Study Site, Austin

79606

Regeneron Study Site, Abilene

80401

Regeneron Study Site, Golden

80909

Regeneron Study Site, Colorado Springs

84107

Regeneron Study Site, Salt Lake City

85020

Regeneron Study Site, Phoenix

85351

Regeneron Study Site, Sun City

87102

Regeneron Study Site, Albuquerque

91436

Regeneron Study Site, Encino

92211

Regeneron Study Site, Palm Desert

92705

Regeneron Study Site, Santa Ana

92835

Regeneron Study Site, Fullerton

94040

Regeneron Study Site, Mountain View

95819

Regeneron Study Site, Sacramento

97221

Regeneron Study Site, Portland

99204

Regeneron Study Site, Spokane

06385

Regeneron Study Site, Waterford

07003

Regeneron Study Site, Bloomfield

07666

Regeneron Study Site, Teaneck

00612

Regeneron Study Site, Arecibo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY